Serum surrogate markers of liver fibrosis in primary biliary cirrhosis

European Journal of Internal Medicine

Volumn 22, Issue 1, 2011, Pages 77-83

  Voumvouraki, Argiro ^a   Koulentaki, Mairi ^a   Notas, George ^a   Sfakianaki, Ourania ^a   Kouroumalis, Elias ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Collagen IV; Hyaluronan; Laminin; Leptin; Primary biliary cirrhosis

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 4; HYALURONIC ACID; LAMININ; LEPTIN; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS;

ADJUVANTS, IMMUNOLOGIC; AGED; ALGORITHMS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; COLLAGEN TYPE IV; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; HYALURONIC ACID; LAMININ; LEPTIN; LIVER CIRRHOSIS; LIVER CIRRHOSIS, BILIARY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 78751588544     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.10.002     Document Type: Article

References (60)

1. T. Poynard, V. Ratziu, F. Charlotte, D. Messous, M. Munteanu, and F. Imbert-Bismut Diagnostic value of biochemical markers (nashtest) for the prediction of non-alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease BMC Gastroenterol 6 2006 34
2. O.A. Gressner, R. Weiskirchen, and A.M. Gressner Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality J Cell Mol Med 11 2007 1031 1051
3. T. Poynard, R. Morra, P. Halfon, L. Castera, V. Ratziu, and F. Imbert-Bismut Meta-analyses of fibrotest diagnostic value in chronic liver disease BMC Gastroenterol 7 2007 40
4. N.C. Chavez-Tapia, and C. Tiribelli Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (nafld)? Gut 57 2008 1351 1353
5. E. Hashimoto, and G.C. Farrell Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis? J Gastroenterol Hepatol 24 2009 501 503
6. F. Vizzutti, U. Arena, V. Nobili, R. Tarquini, M. Trappoliere, and G. Laffi Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease Ann Hepatol 8 2009 89 94
7. T. Poynard, Y. Ngo, M. Munteanu, D. Thabut, J. Massard, and J. Moussalli Biomarkers of liver injury for hepatitis clinical trials: A meta-analysis of longitudinal studies Antivir Ther 15 2010 617 631
8. W.M. Rosenberg, M. Voelker, R. Thiel, M. Becka, A. Burt, and D. Schuppan Serum markers detect the presence of liver fibrosis: A cohort study Gastroenterology 127 2004 1704 1713
9. M.J. Mayo, J. Parkes, B. Adams-Huet, B. Combes, A.S. Mills, and R.S. Markin Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay Hepatology 48 2008 1549 1557
10. H. Rosa, and E.R. Parise Is there a place for serum laminin determination in patients with liver disease and cancer? World J Gastroenterol 14 2008 3628 3632
11. F. Marra, and C. Bertolani Adipokines in liver diseases Hepatology 50 2009 957 969
12. J. Ludwig, E.R. Dickson, and G.S. McDonald Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) Virchows Arch A: Pathol Anat Histol 379 1978 103 112
13. E. Matrella, V. Valatas, G. Notas, H. Roumpaki, C. Xidakis, and A. Hadzidakis Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a no-independent mechanism in chronic liver disease Aliment Pharmacol Ther 15 2001 857 864
14. T. Poynard, P. Halfon, L. Castera, M. Munteanu, F. Imbert-Bismut, and V. Ratziu Standardization of roc curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages Clin Chem 53 2007 1615 1622
15. N.H. Afdhal, and D. Nunes Evaluation of liver fibrosis: A concise review Am J Gastroenterol 99 2004 1160 1174
16. F. Piccinino, E. Sagnelli, G. Pasquale, and G. Giusti Complications following percutaneous liver biopsy: A multicentre retrospective study on 68, 276 biopsies J Hepatol 2 1986 165 173
17. M.C. Garrido, and S.G. Hubscher Accuracy of staging in primary biliary cirrhosis J Clin Pathol 49 1996 556 559
18. M. Friedrich-Rust, C. Muller, A. Winckler, S. Kriener, E. Herrmann, and J. Holtmeier Assessment of liver fibrosis and steatosis in pbc with fibroscan, mri, mr-spectroscopy, and serum markers J Clin Gastroenterol 44 2010 58 65
19. M. Bourliere, G. Penaranda, C. Renou, D. Botta-Fridlund, A. Tran, and I. Portal Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis c patients: Proposal for a pragmatic approach classification without liver biopsies J Viral Hepat 13 2006 659 670
20. J. Parkes, I.N. Guha, P. Roderick, and W. Rosenberg Performance of serum marker panels for liver fibrosis in chronic hepatitis C J Hepatol 44 2006 462 474
21. I.N. Guha, J. Parkes, P. Roderick, D. Chattopadhyay, R. Cross, and S. Harris Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European liver fibrosis panel and exploring simple markers Hepatology 47 2008 455 460
22. V. Nobili, J. Parkes, G. Bottazzo, M. Marcellini, R. Cross, and D. Newman Performance of elf serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease Gastroenterology 136 2009 160 167
23. R.E. Poupon, B. Balkau, J. Guechot, and F. Heintzmann Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: Role of serum markers of connective tissue Hepatology 19 1994 635 640
24. A. Nyberg, A. Engstrom-Laurent, and L. Loof Serum hyaluronate in primary biliary cirrhosis: A biochemical marker for progressive liver damage Hepatology 8 1988 142 146
25. A. Nyberg, U. Lindqvist, and A. Engstrom-Laurent Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis: Relation to clinical symptoms, liver histopathology and outcome J Intern Med 231 1992 485 491
26. T. Remmel, H. Remmel, and V. Salupere Aminoterminal propeptide of type iii procollagen and hyaluronan in patients with primary biliary cirrhosis: Markers of fibrosis in primary biliary cirrhosis J Gastroenterol Hepatol 11 1996 1016 1020
27. M. Farkkila, H. Rautiainen, P. Karkkainen, A.L. Karvonen, H. Nurmi, and O. Niemela Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy Liver Int 28 2008 787 797
28. H. Lydatakis, I.P. Hager, E. Kostadelou, S. Mpousmpoulas, S. Pappas, and I. Diamantis Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease Liver Int 26 2006 864 871
29. J. Guechot, A. Laudat, A. Loria, L. Serfaty, R. Poupon, and J. Giboudeau Diagnostic accuracy of hyaluronan and type iii procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis c evaluated by ROC curve analysis Clin Chem 42 1996 558 563
30. H. Kaneda, E. Hashimoto, S. Yatsuji, K. Tokushige, and K. Shiratori Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease J Gastroenterol Hepatol 21 2006 1459 1465
31. A.M. Gressner, and R. Haarmann Hyaluronic acid synthesis and secretion by rat liver fat storing cells (perisinusoidal lipocytes) in culture Biochem Biophys Res Commun 151 1988 222 229
32. E.R. Parise, A.C. Oliveira, C. Figueiredo-Mendes, V. Lanzoni, J. Martins, and H. Nader Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis c virus infection Liver Int 26 2006 1095 1099
33. L.L. Schiavon, J.L. Narciso-Schiavon, R.J. Carvalho Filho, J.P. Sampaio, J.O. Medina-Pestana, and V.P. Lanzoni Serum levels of ykl-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis c virus infection J Viral Hepat 15 2008 666 674
34. M. Yoneda, H. Mawatari, K. Fujita, K. Yonemitsu, S. Kato, and H. Takahashi Type IV collagen 7 s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage J Gastroenterol 42 2007 375 381
35. T. Fukutomi, S. Sakamoto, H. Isobe, H. Sakai, A. Masumoto, and H. Nawata Clinical significance of the serum levels of the 7 s domain of type IV collagen in patients with primary biliary cirrhosis J Gastroenterol Hepatol 7 1992 596 601
36. M. Shimada, H. Kawahara, K. Ozaki, M. Fukura, H. Yano, and M. Tsuchishima Usefulness of a combined evaluation of the serum adiponectin level, homa-ir, and serum type IV collagen 7 s level to predict the early stage of nonalcoholic steatohepatitis Am J Gastroenterol 102 2007 1931 1938
37. A.M. Gressner, W. Tittor, and J. Kropf The predictive value of serum laminin for portal hypertension in chronic liver diseases Hepatogastroenterology 35 1988 95 100
38. J. Kropf, A.M. Gressner, and A. Negwer Efficacy of serum laminin measurement for diagnosis of fibrotic liver diseases Clin Chem 34 1988 2026 2030
39. S. Yamada, T. Suou, H. Kawasaki, and N. Yoshikawa Clinical significance of serum 7 s collagen in various liver diseases Clin Biochem 25 1992 467 470
40. O. Niemela, L. Risteli, E.A. Sotaniemi, and J. Risteli Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease Eur J Clin Invest 15 1985 132 137
41. D. Schuppan, U. Stolzel, C. Oesterling, and R. Somasundaram Serum assays for liver fibrosis J Hepatol 22 1995 82 88
42. B. Smedsrod, M. Paulsson, and S. Johansson Uptake and degradation in vivo and in vitro of laminin and nidogen by rat liver cells Biochem J 261 1989 37 42
43. I.A. Leclercq, G.C. Farrell, R. Schriemer, and G.R. Robertson Leptin is essential for the hepatic fibrogenic response to chronic liver injury J Hepatol 37 2002 206 213
44. K. Ikejima, Y. Takei, H. Honda, M. Hirose, M. Yoshikawa, and Y.J. Zhang Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat Gastroenterology 122 2002 1399 1410
45. F. Marra Leptin and liver tissue repair: Do rodent models provide the answers? J Hepatol 46 2007 12 18
46. S. Chitturi, G. Farrell, L. Frost, A. Kriketos, R. Lin, and C. Fung Serum leptin in nash correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity? Hepatology 36 2002 403 409
47. R.P. Myers, D. Messous, T. Poynard, and F. Imbert-Bismut Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis c Can J Gastroenterol 21 2007 289 294
48. T. Piche, F. Vandenbos, A. Abakar-Mahamat, G. Vanbiervliet, E.M. Barjoan, and G. Calle The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis c J Viral Hepat 11 2004 91 96
49. R. Testa, R. Franceschini, E. Giannini, A. Cataldi, F. Botta, and A. Fasoli Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis J Hepatol 33 2000 33 37
50. C. Corpechot, A. Poujol-Robert, D. Wendum, M. Galotte, Y. Chretien, and R.E. Poupon Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in udca-treated patients with primary biliary cirrhosis Liver Int 24 2004 187 193
51. G. Sebastiani, and A. Alberti Noninvasive fibrosis biomarkers reduce but not substitute the need for liver biopsy World J Gastroenterol 12 2006 3682 3694
52. R.A. Standish, E. Cholongitas, A. Dhillon, A.K. Burroughs, and A.P. Dhillon An appraisal of the histopathological assessment of liver fibrosis Gut 55 2006 569 578
53. A.K. Burroughs, and E. Cholongitas Non-invasive tests for liver fibrosis: Encouraging or discouraging results? J Hepatol 46 2007 751 755
54. J. McHutchison, T. Poynard, and N. Afdhal Fibrosis as an end point for clinical trials in liver disease: A report of the international fibrosis group Clin Gastroenterol Hepatol 4 2006 1214 1220
55. C. Gluud, J. Brok, Y. Gong, and R.L. Koretz Hepatology may have problems with putative surrogate outcome measures J Hepatol 46 2007 734 742
56. C. Corpechot, A. El Naggar, A. Poujol-Robert, M. Ziol, D. Wendum, and O. Chazouilleres Assessment of biliary fibrosis by transient elastography in patients with pbc and psc Hepatology 43 2006 1118 1124
57. E. Gomez-Dominguez, J. Mendoza, L. Garcia-Buey, M. Trapero, J.P. Gisbert, and E.A. Jones Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis Aliment Pharmacol Ther 27 2008 441 447
58. L. Castera, J. Vergniol, J. Foucher, B. Le Bail, E. Chanteloup, and M. Haaser Prospective comparison of transient elastography, fibrotest, apri, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350
59. R.P. Myers, P. Crotty, G. Pomier-Layrargues, M. Ma, S.J. Urbanski, and M. Elkashab Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy Liver Int 2010
60. V. Ratziu Serum fibrosis markers. Death by validation or a leap of faith? J Hepatol 53 2010 222 224